学术探索
学术期刊
新闻热点
数据分析
智能评审

Selective estrogen-receptor modulators for primary prevention of breast cancer

被引：71
作者：
Fabian, CJ
Kimler, BF
机构：
[1] Univ Kansas, Med Ctr, Dept Internal Med, Kansas City, KS 66160 USA
[2] Univ Kansas, Med Ctr, Dept Radiat Oncol, Kansas City, KS 66160 USA
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2005年 / 23卷 / 08期
关键词：
D O I：
10.1200/JCO.2005.11.005
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
[No abstract available]
引用
收藏
页码：1644 / 1655
页数：12
相关论文
共 207 条
[91]  
GRUBBS CJ, 2003, EFFICACY 2 NEW RXR S, V36
[92]   EFFECTS OF THE ANTIESTROGEN TAMOXIFEN ON LOW-DENSITY-LIPOPROTEIN CONCENTRATIONS AND OXIDATION POSTMENOPAUSAL WOMEN [J].
GUETTA, V ;
LUSH, RM ;
FIGG, WD ;
WACLAWIW, MA ;
CANNON, RO .
AMERICAN JOURNAL OF CARDIOLOGY, 1995, 76 (14) :1072-&
[93]   Estrogen receptor β -: a new dimension in estrogen mechanism of action [J].
Gustafsson, JÅ .
JOURNAL OF ENDOCRINOLOGY, 1999, 163 (03) :379-383
[94]   Comparison of the effects of EM-652 (SCH57068), tamoxifen, toremifene, droloxifene, idoxifene, GW-5638 and raloxifene on the growth of human ZR-75-1 breast tumors in nude mice [J].
Gutman, M ;
Couillard, S ;
Roy, J ;
Labrie, F ;
Candas, B ;
Labrie, C .
INTERNATIONAL JOURNAL OF CANCER, 2002, 99 (02) :273-278
[95]   The estrogen receptor β-isoform (ERβ) of the human estrogen receptor modulates ERα transcriptional activity and is a key regulator of the cellular response to estrogens and antiestrogens [J].
Hall, JM ;
McDonnell, DP .
ENDOCRINOLOGY, 1999, 140 (12) :5566-5578
[96]   Circulating concentrations of insulin-like growth factor-I and risk of breast cancer [J].
Hankinson, SE ;
Willett, WC ;
Colditz, GA ;
Hunter, DJ ;
Michaud, DS ;
Deroo, B ;
Rosner, B ;
Speizer, FE ;
Pollak, M .
LANCET, 1998, 351 (9113) :1393-1396
[97]   Evaluation of an estrogen receptor-β agonist in animal models of human disease [J].
Harris, HA ;
Albert, LM ;
Leathurby, Y ;
Malamas, MS ;
Mewshaw, RE ;
Miller, CP ;
Kharode, YP ;
Marzolf, J ;
Komm, BS ;
Winneker, RC ;
Frail, DE ;
Henderson, RA ;
Zhu, Y ;
Keith, JC .
ENDOCRINOLOGY, 2003, 144 (10) :4241-4249
[98]   Outcomes of tamoxifen chemoprevention for breast cancer in very high-risk women: A cost-effectiveness analysis [J].
Hershman, D ;
Sundararajan, V ;
Jacobson, JS ;
Heitjan, DF ;
Neugut, AI ;
Grann, VR .
JOURNAL OF CLINICAL ONCOLOGY, 2002, 20 (01) :9-16
[99]   The SMRT corepressor is regulated by a MEK-1 kinase pathway: Inhibition of corepressor function is associated with SMRT phosphorylation and nuclear export [J].
Hong, SH ;
Privalsky, ML .
MOLECULAR AND CELLULAR BIOLOGY, 2000, 20 (17) :6612-6625
[100]   High prevalence of premalignant lesions in prophylactically removed breasts from women at hereditary risk for breast cancer [J].
Hoogerbrugge, N ;
Bult, P ;
de Widt-Levert, LM ;
Beex, LV ;
Kiemeney, LA ;
Ligtenberg, MJL ;
Massuger, LF ;
Boetes, C ;
Manders, P ;
Brunner, HG .
JOURNAL OF CLINICAL ONCOLOGY, 2003, 21 (01) :41-45
567891011121314